Holocene Advisors
LLY icon

Holocene Advisors’s Eli Lilly LLY Stock Holding History

Holocene Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-240,000
Closed -$35.5M – 801
2020
Q3 		$35.5M Buy
+240,000
New +$37.1M 0.27% 121

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Holocene Advisors's LLY Position: Q1 2026 in Review

Holocene Advisors increased its Eli Lilly (LLY) stake by 15% in Q1 2026, buying an estimated $24.5M and bringing the position to 187,359 shares worth $172M. The position accounts for 0.42% of the portfolio, ranked #65.

Holocene Advisors first reported a position in LLY in Q4 2017 and has held it in 15 quarters since. The position peaked at $530M in Q2 2025. 4,358 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Holocene Advisors held 187,359 shares of Eli Lilly worth $172M as of Q1 2026.
  • Holocene Advisors bought 24,139 Eli Lilly shares in Q1 2026, an estimated $24.5M.
  • Eli Lilly made up 0.42% of Holocene Advisors's portfolio in Q1 2026, its #65 holding.
  • Holocene Advisors first reported a position in Eli Lilly in Q4 2017 and has held it in 15 quarters since.
  • Holocene Advisors's Eli Lilly position peaked at $530M in Q2 2025.
  • 4,358 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Holocene Advisors's 13F filing for Q1 2026, filed 15 May 2026.